Evidence map›Paper›PMID 37237022›Full record

ArticleNPJ digital medicine2023

Mapping digital health ecosystems in Africa in the context of endemic infectious and non-communicable diseases.

Tsegahun Manyazewal, Mohammed K Ali, Tedla Kebede, Matthew J Magee, Tewodros Getinet, Shivani A Patel, Damen Hailemariam, Cam Escoffery, Yimtubezinash Woldeamanuel, Nardos Makonnen and 4 more

Open access · goldAbstract read
In one paragraph

Article in NPJ digital medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Tsegahun ManyazewalAddis Ababa University, College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia. tsegahunm@gmail.com.ORCID http://orcid.org/0000-0002-8360-7574
Mohammed K AliEmory University, Rollins School of Public Health, Hubert Department of Global Health, Atlanta, GA, USA.ORCID http://orcid.org/0000-0001-7266-2503
Tedla KebedeAddis Ababa University, College of Health Sciences, School of Medicine, Addis Ababa, Ethiopia.
Matthew J MageeEmory University, Rollins School of Public Health, Hubert Department of Global Health, Atlanta, GA, USA.
Tewodros GetinetSt. Paul's Hospital Millennium Medical College, School of Public Health, Addis Ababa, Ethiopia.ORCID http://orcid.org/0000-0003-1992-2470
Shivani A PatelEmory University, Rollins School of Public Health, Hubert Department of Global Health, Atlanta, GA, USA.
Damen HailemariamAddis Ababa University, College of Health Sciences, School of Public Health, Addis Ababa, Ethiopia.
Cam EscofferyEmory University, Rollins School of Public Health, Department of Behavioral, Social, and Health Education Sciences, Atlanta, GA, USA.
Yimtubezinash WoldeamanuelAddis Ababa University, College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Nardos MakonnenUniversity of Virginia, School of Medicine, Department of Emergency Medicine, Charlottesville, VA, USA.
Samrawit SolomonSt. Paul's Hospital Millennium Medical College, School of Public Health, Addis Ababa, Ethiopia.
Wondwossen AmogneAddis Ababa University, College of Health Sciences, Addis Ababa, Ethiopia.
Vincent C MarconiEmory University School of Medicine and Rollins School of Public Health, Atlanta, GA, USA.
Abebaw FekaduAddis Ababa University, College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Addis Ababa University · ETEmory University · USSt. Paul's Hospital Millennium Medical College · ETUniversity of Virginia · US

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Jeffrey M Collins · 2022 to 2026
$5.8M
COllaborative research, implementation, And LEadership training to addresS chronic Conditions across the lifecoursE (COALESCE)D43TW011404 · FIC · EMORY UNIVERSITY · PI ALI, MOHAMMED KUMAIL, HAILEMARIAM, DAMEN · 2019 to 2023
$1.2M
FIC NIH HHS D43 TW011404Medical Research Council MR/M025470/1NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI168386
6 · The paper itself

Abstract

Investments in digital health technologies such as artificial intelligence, wearable devices, and telemedicine may support Africa achieve United Nations (UN) Sustainable Development Goal for Health by 2030. We aimed to characterize and map digital health ecosystems of all 54 countries in Africa in the context of endemic infectious and non-communicable diseases (ID and NCD). We performed a cross-national ecological analysis of digital health ecosystems using 20-year data from the World Bank, UN Economic Commission for Africa, World Health Organization, and Joint UN Programme on HIV/AIDS. Spearman's rank correlation coefficients were used to characterize ecological correlations between exposure (technology characteristics) and outcome (IDs and NCDs incidence/mortality) variables. Weighted linear combination model was used as the decision rule, combining disease burden, technology access, and economy, to explain, rank, and map digital health ecosystems of a given country. The perspective of our analysis was to support government decision-making. The 20-year trend showed that technology characteristics have been steadily growing in Africa, including internet access, mobile cellular and fixed broadband subscriptions, high-technology manufacturing, GDP per capita, and adult literacy, while many countries have been overwhelmed by a double burden of IDs and NCDs. Inverse correlations exist between technology characteristics and ID burdens, such as fixed broadband subscription and incidence of tuberculosis and malaria, or GDP per capita and incidence of tuberculosis and malaria. Based on our models, countries that should prioritize digital health investments were South Africa, Nigeria, and Tanzania for HIV; Nigeria, South Africa, and Democratic Republic of the Congo (DROC) for tuberculosis; DROC, Nigeria, and Uganda for malaria; and Egypt, Nigeria, and Ethiopia for endemic NCDs including diabetes, cardiovascular disease, respiratory diseases, and malignancies. Countries such as Kenya, Ethiopia, Zambia, Zimbabwe, Angola, and Mozambique were also highly affected by endemic IDs. By mapping digital health ecosystems in Africa, this study provides strategic guidance about where governments should prioritize digital health technology investments that require preliminary analysis of country-specific contexts to bring about sustainable health and economic returns. Building digital infrastructure should be a key part of economic development programs in countries with high disease burdens to ensure more equitable health outcomes. Though infrastructure developments alongside digital health technologies are the responsibility of governments, global health initiatives can cultivate digital health interventions substantially by bridging knowledge and investment gaps, both through technology transfer for local production and negotiation of prices for large-scale deployment of the most impactful digital health technologies.

Identifiers

PMID37237022
PMCPMC10213589
OpenAlexW4378378763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.